In addition, some patients with AML exhibit SETBP1 overexpression due to the t(12;18)(p13;q12) chromosomal translocation (36), and patients with atypical CML can have recurrent G870S mutations of SETBP1 (38). This evidence concerns the gene SETBP1 and chronic myelogenous leukemia, BCR-ABL1 positive.